Does PANTOPRAZOLE Cause Immune-mediated hepatitis? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Immune-mediated hepatitis have been filed in association with PANTOPRAZOLE (Pantoprazole Sodium). This represents 0.0% of all adverse event reports for PANTOPRAZOLE.
5
Reports of Immune-mediated hepatitis with PANTOPRAZOLE
0.0%
of all PANTOPRAZOLE reports
4
Deaths
5
Hospitalizations
How Dangerous Is Immune-mediated hepatitis From PANTOPRAZOLE?
Of the 5 reports, 4 (80.0%) resulted in death, 5 (100.0%) required hospitalization.
Is Immune-mediated hepatitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PANTOPRAZOLE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does PANTOPRAZOLE Cause?
Chronic kidney disease (28,127)
Acute kidney injury (15,961)
Renal failure (11,543)
End stage renal disease (8,523)
Renal injury (7,070)
Drug ineffective (5,487)
Off label use (4,279)
Pain (4,057)
Dyspnoea (4,052)
Fatigue (3,797)
What Other Drugs Cause Immune-mediated hepatitis?
NIVOLUMAB (640)
PEMBROLIZUMAB (549)
IPILIMUMAB (443)
CARBOPLATIN (213)
PACLITAXEL (167)
ATEZOLIZUMAB (142)
BEVACIZUMAB (108)
DURVALUMAB (90)
LENVATINIB (86)
PEMETREXED (86)
Which PANTOPRAZOLE Alternatives Have Lower Immune-mediated hepatitis Risk?
PANTOPRAZOLE vs PANTOPRAZOLE ANHYDROUS
PANTOPRAZOLE vs PANTOTHENIC ACID
PANTOPRAZOLE vs PAPAVERINE
PANTOPRAZOLE vs PARACETAMOL
PANTOPRAZOLE vs PARATHYROID HORMONE